相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MRI versus 18F-FDG-PET/CT for detecting bone marrow involvement in multiple myeloma: diagnostic performance and clinical relevance
Frederic E. Lecouvet et al.
EUROPEAN RADIOLOGY (2020)
Multiple myeloma: 2020 update on diagnosis, risk-stratification and management
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma
Charles Mesguich et al.
ANNALS OF HEMATOLOGY (2020)
Low hexokinase-2 expression-associated false-negative 18F-FDG PET/CT as a potential prognostic predictor in patients with multiple myeloma
Yoshiaki Abe et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)
Christina Messiou et al.
RADIOLOGY (2019)
Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma
Cristina Nanni et al.
PET CLINICS (2019)
Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or F-18-fluorodeoxyglucose positron emission tomography/CT (F-18-FDG PET/CT) in patients with myeloma: Systematic review of diagnostic performance
Joanna Gariani et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Diagnostic performance of F-18-FDG PET/CT and whole-body MRI before and early after treatment of multiple myeloma: a prospective comparative study
Mohammad Abd Alkhalik Basha et al.
JAPANESE JOURNAL OF RADIOLOGY (2018)
Diagnostic performance of F-18-FDG PET/CT and whole-body MRI before and early after treatment of multiple myeloma: a prospective comparative study
Mohammad Abd Alkhalik Basha et al.
JAPANESE JOURNAL OF RADIOLOGY (2018)
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma
Leo Rasche et al.
BLOOD (2017)
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
E. Zamagni et al.
LEUKEMIA (2016)
Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?
C. Pawlyn et al.
LEUKEMIA (2016)
New Perspectives Offered by Nuclear Medicine for the Imaging and Therapy of Multiple Myeloma
Charles Mesguich et al.
THERANOSTICS (2016)
Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study
Giuseppe Lucio Cascini et al.
RADIOLOGIA MEDICA (2013)
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
Elena Zamagni et al.
BLOOD (2011)
Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
Jens Hillengass et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Whole-Body MRI Versus PET in Assessment of Multiple Myeloma Disease Activity
Conor P. Shortt et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2009)
Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma
Richard J. Breyer et al.
SKELETAL RADIOLOGY (2006)
分享论文
